SFG
JAZZ icon

Steward Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Steward Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$6K Buy
+52
New +$6.93K ﹤0.01% 548
2023
Q2 		– Sell
-28
Closed -$4K – 732
2023
Q1 		$4K Buy
28
+7
+33% +$1.03K ﹤0.01% 358
2022
Q4 		$3K Buy
+21
New +$3.08K ﹤0.01% 269
2022
Q3 		– Sell
-22
Closed -$3K – 702
2022
Q2 		$3K Buy
+22
New +$3.39K ﹤0.01% 460

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Steward Financial Group's JAZZ Position: Q3 2023 in Review

Steward Financial Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2023: 52 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #548 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in JAZZ as recently as Q1 2023.

Steward Financial Group first reported a position in JAZZ in Q2 2022 and has held it in 4 quarters since. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Steward Financial Group held 52 shares of Jazz Pharmaceuticals worth $6K as of Q3 2023.
  • Jazz Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Jazz Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #548 holding.
  • Steward Financial Group first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.